Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | PARP14 | Q460N5 | 4/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16429257 | 0.92 | ALDH1A1 (0.57) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL5623725 | 0.90 | ALDH1A1 (0.71) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL15275557 | 0.88 | ALDH1A1 (0.53) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL19448679 | 0.88 | ALDH1A1 (0.54) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL6689158 | 0.87 | ALDH1A1 (0.74) | ALDH1A1HPGDSMN1; SMN2MAOACYP2C19 | |
| SCHEMBL9762630 | 0.87 | ALDH1A1 (0.57) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL99181 | 0.87 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL21522574 | 0.87 | ALDH1A1 (0.52) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL29588117 | 0.87 | MAOA (0.58) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA | |
| SCHEMBL19451109 | 0.85 | PARP14 (0.56) | ALDH1A1HPGDKDM4ESMN1; SMN2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349790-A | Preparation method of phosphine oxide type TADF (TADF-based organic photoelectric material) | 安阳工学院 | 2022-04-15 | — | — | CN | claimed |
| US-6979749-B2 | Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-12-27 | — | — | US | claimed |
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-29 | — | — | US | claimed |
| CN-114349790-A | Preparation method of phosphine oxide type TADF (TADF-based organic photoelectric material) | 安阳工学院 | 2022-04-15 | — | — | CN | disclosed |
| US-6979749-B2 | Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | NNMT, CBR3, POR | ALDH1A1 208/4885HPGD 1008/4885KDM4E 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.